Navigation Links
IMRIS receives CE Mark approval for interventional imaging system
Date:4/30/2009

WINNIPEG, April 30 /PRNewswire-FirstCall/ - IMRIS Inc. (TSX: IM) ("IMRIS" or the "Company") today announced CE Mark approval for its integrated MR imaging and x-ray angiography suite that enables physicians to diagnose, intervene, resolve and confirm the effectiveness of treatment with one integrated system. With CE Mark approval, IMRIS will immediately commence marketing in Europe of two products: IMRISNV for stroke management and advanced neurovascular interventions and IMRIScardio for cardiovascular interventions.

IMRISNV features a 3T MRI scanner and a bi-plane angiography system specifically designed to co-exist in the same suite. Patients with acute ischemic stroke transition seamlessly from MR imaging to intervention without moving from the table. During and after the intervention, new MR images can be taken to assess the effectiveness of the treatment. IMRISNV is designed to shorten transition time between imaging modalities, decrease the overall time for treatment and improve patient outcomes.

IMRIScardio features a 1.5T MRI scanner that provides images that can improve the physician's ability to visualize the cardiovascular system before, during and after an intervention. With an integrated single-plane angiography system, IMRIScardio is designed to improve patient outcomes by decreasing the overall time for cardiovascular interventions and minimizing the patient's exposure to radiation and contrast media.

"CE Mark approval of our system represents our first step into the realm of neurovascular and cardiovascular interventional imaging", stated David Graves, CEO of IMRIS. "We are excited about launching our technology in Europe and we are confident that IMRISNV and IMRIScardio will help physicians and hospitals improve the outcomes of their patients suffering from a wide range of neurovascular and cardiovascular conditions."

About CE Mark

The CE Mark for medical devices is not a quality mark nor is it intended for consumers. It is a legally binding statement by the manufacturer that their product has met all of the requirements of the Medical Devices Directive (MDD 93/42/EEC), In Vitro Diagnostic Device Directive (IVD 98/79/EC) or the Active Implantable Medical Device Directive (AIMD 90/385/EEC), where applicable.

About IMRIS

IMRIS (TSX: IM) is a global leader in providing fully integrated, advanced surgical imaging solutions. The company's flagship product, IMRISneuro, utilizes patented technology that allows a high field MRI scanner to be moved in to the operating room on demand, providing imaging during the surgical procedure without compromising patient safety. This unique and innovative system has been validated by leading neurosurgeons for use in world-class neuroscience centers. For more information, visit www.imris.com.


'/>"/>
SOURCE IMRIS Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Huashan Hospital to install Asias first 3T IMRIS system for neurosurgery
2. IMRIS announces development program for MR guided radiation and interventional applications
3. IMRIS announces first IMRISneuro project in Australia
4. IMRISneuro: The iMRI technology of choice among the worlds top ranked hospitals
5. IMRISneuro at Central DuPage Hospital will be the first in the Chicago area
6. Dell Childrens Medical Center to install IMRISneuro in expanded neurocenter
7. Senior GE Executive to lead IMRIS Sales team in the U.S.
8. University of Virginia Health System invests in IMRISneuro, the next generation of surgical imaging technology
9. Providence St. Vincent bringing IMRISneuro, the worlds most advanced surgical MRI to Portland, Oregon
10. Insulet Receives CE Mark for the OmniPod(R) Insulin Management System
11. Houston Northwest Medical Center Receives Prestigious Tenet Circle of Excellence Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with ... Latin America . ... ... ... ...
Breaking Medicine Technology: